S-Adenosyl-L-Methionine

Parkinson's Disease

NYU Langone HealthPhase 2/3Dormant

CCC

55/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 46/ 100
Competitive Position: 73/ 100

Competitive context

52 Active assets in the Parkinson's Disease cohort.

Asset / Sponsor	Phase	Rating
Tvp-1012 Guangzhou Henovcom Bioscience Co. Ltd.	Phase 4	BBB
Istradefylline Georgetown University	Phase 4	BBB
LEVODOPA Ihab Elsayed Hassan	Phase 4	BBB
carbidopa Tanta University	Phase 4	BBB
Entacapone University Hospital Tuebingen	Phase 4	BBB

View all 50 →

Same molecule, other indications

S-Adenosyl-L-Methionine is also rated in:

Fatty Liver, NonalcoholicDormant

BB

Indicative ·

69 / 100

metabolic dysfunction-associated steatotic liver diseaseDormant

BB

Indicative ·

64 / 100

depressive disorderDormant

B

Indicative ·

63 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.